Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Psoriasis patients monitored for two years on newer biologic drug

NCT ID NCT07582783

Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 3 times

Summary

This study watches 200 adults with moderate-to-severe plaque psoriasis who have never taken a biologic before. They are starting treatment with guselkumab, and researchers will track how many continue the drug for two years. The goal is to see how well people stick with this treatment over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Nov 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants with moderate-to-severe plaque psoriasis, in accordance with clinical practice in Romania, who have never been treated with biological treatment before will be observed.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Has a confirmed diagnosis of moderate-to-severe plaque psoriasis * Participant must sign an informed consent form allowing source data verification in accordance with local requirements * Is able to read, understand, and complete the patient reported outcomes (PRO) instruments in local language and comply with completion of all PRO instruments * No previous exposure to biological treatment, including guselkumab (bio-naive patient) * Intended for the treatment with guselkumab according to the approved indication Exclusion criteria: * Meets any of the contraindications according to the latest version of the locally approved summary of product characteristics (SmPC) * Is pregnant or lactating * Current or recent (in the last 30 days prior to first SC dose of guselkumab) participation in any interventional study with investigational product. * Currently enrolled in another observational study sponsored or managed by a Johnson \& Johnson company

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Psoriasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Psoriasis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    19 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alin Nicolescu Medic Primar Dermato Venerologie

    RECRUITING

    Bucharest, 030167, Romania

  • Ambulator Specialitate Sp Militar de Urgenta Dr Constantin Papilian Cluj Napoca

    RECRUITING

    Cluj-Napoca, 400132, Romania

  • Clinica Cabimed

    RECRUITING

    Targu Mureș, 540119, Romania

  • Derma Lux SRL

    RECRUITING

    Iași, 700126, Romania

  • Derma Lux SRL 1

    RECRUITING

    Reghin, 545300, Romania

  • Dr Tirziu Dermato Chirurgie SRL

    RECRUITING

    Timișoara, 300188, Romania

  • Evaderm Health SRL

    RECRUITING

    Slatina, 230086, Romania

  • Innovative Derm SRL

    RECRUITING

    Constanța, 900562, Romania

  • Mihaila G. Georgiana - Cabinet Medical Individual Dermatovenerologie

    RECRUITING

    Bârlad, 731139, Romania

  • OptiDerm Estet

    RECRUITING

    Bucharest, 111870, Romania

  • Policlinica Dr.Corbeanu

    RECRUITING

    Craiova, 200157, Romania

  • Policlinica Top Med Buna Vestire

    RECRUITING

    Craiova, 200330, Romania

  • Qualimed SRL

    RECRUITING

    Brasov, 500073, Romania

  • Spitalul Clinic Colentina

    RECRUITING

    Bucharest, 020125, Romania

  • Spitalul Clinic Colentina 1

    RECRUITING

    Bucharest, 020125, Romania

  • Spitalul Clinic Judetean de Urgenta Bihor

    RECRUITING

    Oradea, 410167, Romania

  • Spitalul Clinic Judetean de Urgenta Cluj Napoca

    RECRUITING

    Cluj-Napoca, 400006, Romania

  • Spitalul Judetean de Urgenta 'Sf.Ioan cel Nou', Sectia Oncologie

    RECRUITING

    Suceava, 720224, Romania

  • Spitalul Universitar de Urgenta Elias, Clinica de Cardiologie

    RECRUITING

    Bucharest, 011461, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.